Source:http://linkedlifedata.com/resource/pubmed/id/18938084
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
2008-11-5
|
pubmed:abstractText |
A number of 1,3-dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines were prepared and evaluated as ligands of recombinant human adenosine receptors (hARs). Several 1,3-dipropyl derivatives endowed with nanomolar binding affinity at hA(2B) receptors, but poor selectivity over hA(2A), hA(1) and hA(3) AR subtypes were identified. A comparison with the corresponding 7-OH- and 7,9-unsubstituted-deazaxanthines revealed that 9-OH-9-deazaxanthines are more potent hA(2B) ligands with lower partition coefficients and higher water solubility compared to the other two congeneric classes of deazaxanthines. An optimization of the para-substituent of the 8-phenyl ring of 9-OH-9-deazaxanthines led to the discovery of compound 38, which exhibited outstanding hA(2B) affinity (Ki=1.0 nM), good selectivity over hA(2A), hA(1) and hA(3) (selectivity indices=100, 79 and 1290, respectively) and excellent antagonist potency in a functional assay on rat A(2B) (pA(2B)=9.33).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1464-3391
|
pubmed:author |
pubmed-author:BreaJose ManuelJM,
pubmed-author:CampagnaFrancescoF,
pubmed-author:CarottiAngeloA,
pubmed-author:CellamareSaverioS,
pubmed-author:GavuzzoEnricoE,
pubmed-author:LeonettiFrancescoF,
pubmed-author:LozaMaria IsabelMI,
pubmed-author:MazzaFernandoF,
pubmed-author:NicolottiOrazioO,
pubmed-author:StefanachiAngelaA
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9780-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18938084-Adenosine A2 Receptor Antagonists,
pubmed-meshheading:18938084-Animals,
pubmed-meshheading:18938084-CHO Cells,
pubmed-meshheading:18938084-Cricetinae,
pubmed-meshheading:18938084-Cricetulus,
pubmed-meshheading:18938084-Drug Design,
pubmed-meshheading:18938084-Humans,
pubmed-meshheading:18938084-Models, Molecular,
pubmed-meshheading:18938084-Molecular Structure,
pubmed-meshheading:18938084-Rats,
pubmed-meshheading:18938084-Receptor, Adenosine A2B,
pubmed-meshheading:18938084-Structure-Activity Relationship,
pubmed-meshheading:18938084-Xanthines
|
pubmed:year |
2008
|
pubmed:articleTitle |
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
|
pubmed:affiliation |
Dipartimento Farmaco-chimico, Università degli Studi di Bari, via Orabona 4, I-70125 Bari, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|